Clinical Trial Update: Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated the combination of lapatinib and topotecan in patients with ovarian cancer or primary peritoneal cancer that did not respond to cisplati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Lapatinib (Lapatinib)
• Topotecan (topotecan)

Snippet

Sponsor: Mayo Clinic | Conditions: Ovarian Cancer, Peritoneal Cavity Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-03-22